WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

• Peter A van Veelen,
• Marieke Griffioen,
• Arnoud H de Ru,
• Anne K Wouters,
• Dennis F G Remst,
• J H Frederik Falkenburg,
• Mirjam H M Heemskerk,
• Rosa A van Amerongen,
• Renate S Hagedoorn,
• Danique C Assendelft,
• Dirk M van der Steen,
• Marian van de Meent,
• Michel G D Kester

Affiliations

Peter A van Veelen

Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

Marieke Griffioen

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Arnoud H de Ru

2 Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands

Anne K Wouters

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Dennis F G Remst

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

J H Frederik Falkenburg

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Mirjam H M Heemskerk

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Rosa A van Amerongen

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Renate S Hagedoorn

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Danique C Assendelft

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Dirk M van der Steen

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Marian van de Meent

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands

Michel G D Kester

Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands